| Exosomes as drug delivery systems: A brief overview and progress update SM Patil, SS Sawant, NK Kunda European Journal of Pharmaceutics and Biopharmaceutics 154, 259-269, 2020 | 140 | 2020 |
| Nanocarriers targeting dendritic cells for pulmonary vaccine delivery NK Kunda, S Somavarapu, SB Gordon, GA Hutcheon, IY Saleem Pharmaceutical research 30, 325-341, 2013 | 117 | 2013 |
| Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer X Wang, V Parvathaneni, SK Shukla, NS Kulkarni, A Muth, NK Kunda, ... International Journal of Biological Macromolecules 164, 638-650, 2020 | 79 | 2020 |
| An overview of nanocarrier-based adjuvants for vaccine delivery KC Petkar, SM Patil, SS Chavhan, K Kaneko, KK Sawant, NK Kunda, ... Pharmaceutics 13 (4), 455, 2021 | 77 | 2021 |
| Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles NK Kunda, IM Alfagih, EN Miyaji, DB Figueiredo, VM Gonçalves, ... International journal of pharmaceutics 495 (2), 903-912, 2015 | 75 | 2015 |
| Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro R Vartak, SM Patil, A Saraswat, M Patki, NK Kunda, K Patel Nanomedicine 16 (14), 1187-1202, 2021 | 74 | 2021 |
| Bovine Serum Albumin Adsorbed PGA-co-PDL Nanocarriers for Vaccine Delivery via Dry Powder Inhalation NK Kunda, IM Alfagih, SR Dennison, HM Tawfeek, S Somavarapu, ... Pharmaceutical research 32, 1341-1353, 2015 | 73 | 2015 |
| Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics B Vaidya, NS Kulkarni, SK Shukla, V Parvathaneni, G Chauhan, ... International journal of pharmaceutics 577, 118995, 2020 | 67 | 2020 |
| Antimicrobial peptides as novel therapeutics for non-small cell lung cancer NK Kunda Drug discovery today 25 (1), 238-247, 2020 | 67 | 2020 |
| Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment V Parvathaneni, NS Kulkarni, SK Shukla, PT Farrales, NK Kunda, A Muth, ... Pharmaceutics 12 (3), 206, 2020 | 65 | 2020 |
| Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD) A Mohamed, NK Kunda, K Ross, GA Hutcheon, IY Saleem European Journal of Pharmaceutics and Biopharmaceutics 136, 1-8, 2019 | 63 | 2019 |
| Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection TC Rodrigues, MLS Oliveira, A Soares-Schanoski, SL Chavez-Rico, ... PloS one 13 (1), e0191692, 2018 | 62 | 2018 |
| In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles DN Price, LR Stromberg, NK Kunda, P Muttil Molecular pharmaceutics 14 (12), 4741-4750, 2017 | 62 | 2017 |
| Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design KC Petkar, S Chavhan, N Kunda, I Saleem, S Somavarapu, KMG Taylor, ... AAPS PharmSciTech 19, 1758-1772, 2018 | 59 | 2018 |
| Microbes as medicines: harnessing the power of bacteria in advancing cancer treatment SS Sawant, SM Patil, V Gupta, NK Kunda International journal of molecular sciences 21 (20), 7575, 2020 | 58 | 2020 |
| Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer L Zhai, R Yadav, NK Kunda, D Anderson, E Bruckner, EK Miller, R Basu, ... Antiviral research 166, 56-65, 2019 | 57 | 2019 |
| Polymer‐based Delivery Systems for the Pulmonary Delivery of Biopharmaceuticals NK Kunda, IM Alfagih, IY Saleem, GA Hutcheon Pulmonary Drug Delivery: Advances and Challenges, 301-320, 2015 | 57* | 2015 |
| Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC) SM Patil, SS Sawant, NK Kunda International Journal of Pharmaceutics 607, 121046, 2021 | 56 | 2021 |
| Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy RS Elbatanony, V Parvathaneni, NS Kulkarni, SK Shukla, G Chauhan, ... Drug delivery and translational research 11, 927-943, 2021 | 55 | 2021 |
| Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer SK Shukla, NS Kulkarni, P Farrales, DD Kanabar, V Parvathaneni, ... Pharmaceutical research 37, 1-19, 2020 | 54 | 2020 |
imran saleemProfessor in nanomedicine, Liverpool John Moores University在 ljmu.ac.uk 的电子邮件经过验证
